Anti-Myelin basic protein (IgM)

Optimal result: 0.1 – 10 Units

Anti-myelin basic protein (-MBP) autoantibodies have generally been considered to be absent from sera from healthy individuals, but to be detectable in sera from some patients with multiple sclerosis (MS). However, their pathogenic role is uncertain. 

MS is a chronic, progressive disease of the central nervous system (CNS) that occurs when the immune system attacks and damages the myelin sheath around nerve fibers.

However, it is important to note that the presence of anti-MBP antibodies alone is not diagnostic of MS, and additional testing and evaluation by a healthcare professional are necessary to determine the underlying cause of the antibody presence and any associated symptoms.

Myelin basic protein (MBP) is a protein believed to be important in the process of myelination of nerves in the nervous system. Anti-Myelin basic protein is related to the risk for multiple sclerosis, autism, PANDAS/ANDAS/OCD, and systemic lupus erythematosus (SLE).

Myelin basic protein (MBP) is a protein believed to be important in the process of myelination of nerves in the nervous system. Anti-Myelin basic protein is related to the risk for multiple sclerosis, autism, PANDAS/ANDAS/OCD, and systemic lupus erythematosus (SLE).

MBP is the most widely studied myelin protein in MS and the second most abundant myelin protein after the proteolipid protein that constitutes the myelin sheath, which is necessary for the normal activity of the vertebrate nervous system.

References:

Hedegaard CJ, Chen N, Sellebjerg F, Sørensen PS, Leslie RG, Bendtzen K, Nielsen CH. Autoantibodies to myelin basic protein (MBP) in healthy individuals and in patients with multiple sclerosis: a role in regulating cytokine responses to MBP. Immunology. 2009 Sep;128(1 Suppl):e451-61. doi: 10.1111/j.1365-2567.2008.02999.x. Epub 2008 Dec 18. PMID: 19191913; PMCID: PMC2753924.

Rozenblum GT, Kaufman T, Vitullo AD. Myelin Basic Protein and a Multiple Sclerosis-related MBP-peptide Bind to Oligonucleotides. Mol Ther Nucleic Acids. 2014 Sep 9;3(9):e192. doi: 10.1038/mtna.2014.43. PMID: 25202925; PMCID: PMC4222649.

Anti-Myelin basic protein (IgM)
Healthmatters dashboard showing biomarker trend graph

Every lab result you’ve ever had, charted and explained.

Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.

Start with my report →
Beyond Anti-Myelin basic protein (IgM) — 10,000+ markers explained
One Anti-Myelin basic protein (IgM) result tells you where you are. Your history tells you where you’re heading. Upload your past lab reports and see this marker — and every marker on them —every marker charted against your own lab’s ranges.
Start with this report →
Healthmatters timeline preview showing biomarker trends over time
Clinical Sources & References

All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.

Article Review Log
Written by Healthmatters Editorial Team
Healthmatters Lifetime Plan

Pay $250. Track your health forever

One payment. No renewals. Yours for life.

10,000+ biomarkers explained · trends over time

See other plans →
Secure checkout via Stripe · GDPR & HIPAA
We accept results from any lab
LabCorp Quest Diagnostics Genova Diagnostics DUTCH Test Doctor's Data Vibrant America ZRT Laboratory Cyrex Labs + any other lab

What members are saying

★★★★★ 10,000+ happy members
★★★★★

"Watching my numbers move over the years — instead of forgetting last time's results — completely changed how I manage my health."

Daniel
Member since 2022
★★★★★

"Living across several countries made keeping my lab results organized a real challenge. Healthmatters brought my results from the USA, Spain, and Germany together — 20 years of history, with long-term trends instead of scattered reports."

Ben
Member since 2021 · tracks across countries
★★★★★

"Standard lab ranges are too wide for how I practice — 'normal' isn't optimal. I set my own bands, so a client sees yellow before a marker goes officially out of range. That's the conversation I want to be having."

Dr. Alexandra
Functional medicine · 6 yrs on Pro